Europe — Product revenues, net
Vertex Pharmaceuticals Europe — Product revenues, net increased by 14.9% to $950.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.9%, from $826.60M to $950.00M. Over 2 years (FY 2022 to FY 2024), Europe — Product revenues, net shows an upward trend with a 13.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests successful market penetration, strong demand for the company's therapies, or favorable pricing adjustments in the region. A decrease may indicate increased competition, regulatory pricing pressure, or a decline in patient adoption rates.
Detailed definition
This metric represents the total net sales generated from pharmaceutical products within the European geographic segment...
Peer comparison
Comparable to regional revenue reporting for other global biopharmaceutical companies, often benchmarked against total international revenue growth rates.
vrtx_segment_europe_product_revenues_netHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $458.91M | $518.83M | $632.30M | $655.50M | $730.50M | $687.20M | $807.20M | $800.00M | $766.50M | $735.30M | $967.40M | $806.80M | $847.70M | $832.00M | $826.60M | $950.00M |
| QoQ Change | — | +13.1% | +21.9% | +3.7% | +11.4% | -5.9% | +17.5% | -0.9% | -4.2% | -4.1% | +31.6% | -16.6% | +5.1% | -1.9% | -0.6% | +14.9% |
| YoY Change | — | — | — | +42.8% | +40.8% | — | +27.7% | +22.0% | +4.9% | +7.0% | +19.8% | +0.9% | +10.6% | +13.2% | -14.6% | +14.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's europe — product revenues, net?
- Vertex Pharmaceuticals (VRTX) reported europe — product revenues, net of $950.00M in Q1 2026.
- How has Vertex Pharmaceuticals's europe — product revenues, net changed year-over-year?
- Vertex Pharmaceuticals's europe — product revenues, net increased by 14.9% year-over-year, from $826.60M to $950.00M.
- What is the long-term trend for Vertex Pharmaceuticals's europe — product revenues, net?
- Over 2 years (2022 to 2024), Vertex Pharmaceuticals's europe — product revenues, net has grown at a 13.0% compound annual growth rate (CAGR), from $2.71B to $3.45B.
- What does europe — product revenues, net mean?
- The total net revenue earned from selling pharmaceutical products in the European market.